| Can positive framing reduce nocebo side effects? Current evidence and recommendation for future research K Barnes, K Faasse, AL Geers, SG Helfer, L Sharpe, L Colloca, ... Frontiers in Pharmacology 10, 167, 2019 | 92 | 2019 |
| Supernatural agency: Individual difference predictors and situational correlates K Barnes, NJS Gibson International Journal for the Psychology of Religion 23 (1), 42-62, 2013 | 48 | 2013 |
| Experimental assessment of nocebo effects and nocebo side effects: definitions, study design, and implications for psychiatry and beyond K Faasse, SG Helfer, K Barnes, B Colagiuri, AL Geers Frontiers in psychiatry 10, 396, 2019 | 28 | 2019 |
| Deceptive but not open label placebos attenuate motion-induced nausea K Barnes, A Yu, J Josupeit, B Colagiuri Journal of Psychosomatic Research 125, 109808, 2019 | 19 | 2019 |
| Using positive attribute framing to attenuate nocebo side effects: A cybersickness study A Mao, K Barnes, L Sharpe, AL Geers, SG Helfer, K Faasse, B Colagiuri Annals of Behavioral Medicine 55 (8), 769-778, 2021 | 17 | 2021 |
| Instrumental control enhances placebo analgesia B Tang, A Geers, K Barnes, B Colagiuri The journal of pain 20 (12), 1486-1497, 2019 | 16 | 2019 |
| Choice and the placebo effect: a meta-analysis B Tang, K Barnes, A Geers, E Livesey, B Colagiuri Annals of Behavioral Medicine 56 (10), 977-988, 2022 | 13 | 2022 |
| In anticipation of pain: expectancy modulates corticospinal excitability, autonomic response, and pain perception K Barnes, NA McNair, JA Harris, L Sharpe, B Colagiuri Pain 162 (8), 2287-2296, 2021 | 11 | 2021 |
| Pre-exposure, but not overshadowing, inhibits nocebo hyperalgesia B Colagiuri, J Park, K Barnes, L Sharpe, RA Boakes, L Colloca, ... The Journal of Pain 22 (7), 864-877, 2021 | 10 | 2021 |
| Longevity of Post-Explantation Systemic Symptom Improvement and Potential Etiologies: Findings From the ASERF Systemic Symptoms in Women - Biospecimen Analysis Study: Part 4 C Glicksman, P McGuire, M Kadin, K Barnes, R Wixtrom, M Lawrence, ... Aesthetic Surgery Journal, 2023 | 9 | 2023 |
| Positive attribute framing increases COVID-19 booster vaccine intention for unfamiliar vaccines K Barnes, B Colagiuri Vaccines 10 (6), 962, 2022 | 7 | 2022 |
| Can positive framing reduce nocebo side effects? current evidence and recommendation for future research. Front Pharmacol 2019; 10: 167 K Barnes, K Faasse, AL Geers, SG Helfer, L Sharpe, L Colloca, ... | 7 | 2019 |
| More than a feeling? An expanded investigation of emotional responsiveness in young children with conduct problems and callous-unemotional traits JC Northam, H Dar, DJ Hawes, K Barnes, NA McNair, CA Fisher, ... Development and Psychopathology 35 (2), 494-508, 2023 | 6 | 2023 |
| The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample K Barnes, K Faasse, B Colagiuri Vaccine 41 (12), 2046-2054, 2023 | 6 | 2023 |
| The influence of video-based social modelling on the nocebo effect V Quinn, S Pearson, A Huynh, K Nicholls, K Barnes, K Faasse Journal of Psychosomatic Research 165, 111136, 2023 | 6 | 2023 |
| Factors Moderating the Link between Personal Recounts of COVID-19 Vaccine Side Effects Viewed on Social Media and Viewer Postvaccination Experience W Tan, B Colagiuri, K Barnes Vaccines 10 (10), 1611, 2022 | 6 | 2022 |
| Peer-to-peer: The Social Transmission of Symptoms Online W Tan, B Pickup, K Faasse, B Colagiuri, K Barnes Annals of Behavioral Medicine, kaac081, 2023 | 5 | 2023 |
| The role of positive information provision in open‐label placebo effects K Barnes, E Babbage, J Barker, N Jain, K Faasse Applied Psychology: Health and Well-Being, 2023 | 4 | 2023 |
| Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia K Barnes, B Colagiuri Vaccines 10 (10), 1730, 2022 | 3 | 2022 |
| The placebo effect: To explore or to exploit? K Barnes, BM Rottman, B Colagiuri Cognition 214, 104753, 2021 | 3 | 2021 |
Ben ColagiuriUniversity of SydneyVerified email at sydney.edu.au
